CNE100001KV8
CNE100001KV8
TIGERMED
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | 6.832.800.615 | 6.603.120.163 | 3.5% |
| Cost of Revenue | 4.959.606.316 | 4.361.106.946 | 13.7% |
| Gross Profit | 1.873.194.300 | 2.242.013.217 | 16.5% |
| 1.206.551.842 | 1.174.023.760 | 2.8% | |
| Operating Income | 666.642.458 | 1.067.989.457 | 37.6% |
| Pretax Income | 1.003.215.120 | 664.461.508 | 51.0% |
| Net Income Common Stockholders | 887.890.076 | 405.143.492 | 119.2% |
| -- | -- | -- | |
| -- | -- | -- |